- Corporate Officers - A
- Atlas Venture Associates X, Llc
Insider Trading History of Atlas Venture Associates X, Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Atlas Venture Associates X, Llc since 2019.
This trader's CIK number is 1742765.
At the time of last reporting, Atlas Venture Associates X, Llc was the 10% Owner of Disc Medicine, Inc.. (stock ticker symbol IRON).
Also see all insider trading activities at Disc Medicine, Inc..
Note that in the past
Atlas Venture Associates X, LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Disc Medicine, Inc. (IRON) by Atlas Venture Associates X, Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | IRON | 0 | $0 | 357,449 | $18,991,727 | 0 | $0 |
Yearly summary of insider trading at Generation Bio Co. (GBIO) by Atlas Venture Associates X, Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | GBIO | 0 | $0 | 267,777 | $7,287,005 | 0 | $0 |
Yearly summary of insider trading at Avrobio, Inc. (AVRO) by Atlas Venture Associates X, Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | AVRO | 810,811 | $15,000,003 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dianthus Therapeutics, Inc. /de/ (MGTA) by Atlas Venture Associates X, Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | MGTA | 0 | $0 | 14,245 | $254,415 | 0 | $0 |
Yearly summary of insider trading at Kymera Therapeutics, Inc. (KYMR) by Atlas Venture Associates X, Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | KYMR | 0 | $0 | 471,483 | $27,728,388 | 0 | $0 |
Insider trading activities at 5 companies by Atlas Venture Associates X, Llc:
1. Disc Medicine, Inc. (IRON)
2. Generation Bio Co. (GBIO)
3. Avrobio, Inc. (AVRO)
4. Dianthus Therapeutics, Inc. /de/ (MGTA)
5. Kymera Therapeutics, Inc. (KYMR)
Table 1. Insider trading of Disc Medicine, Inc. (IRON) by Atlas Venture Associates X, Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-09-14 | IRON | Sale | 94,440 | 53.05 | 5,010,042 |
2023-09-15 | IRON | Sale | 260,894 | 53.16 | 13,869,125 |
2023-09-16 | IRON | Sale | 2,115 | 53.22 | 112,560 |
Table 2. Insider trading of Generation Bio Co. (GBIO) by Atlas Venture Associates X, Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-04-12 | GBIO | Sale | 74,124 | 26.34 | 1,952,426 |
2021-04-13 | GBIO | Sale | 43,145 | 25.31 | 1,091,999 |
2021-04-14 | GBIO | Sale | 23,413 | 26.59 | 622,551 |
2021-04-08 | GBIO | Sale | 43,550 | 28.68 | 1,249,231 |
2021-04-09 | GBIO | Sale | 43,681 | 27.96 | 1,221,320 |
2021-04-07 | GBIO | Sale | 39,864 | 28.84 | 1,149,478 |
Table 3. Insider trading of Avrobio, Inc. (AVRO) by Atlas Venture Associates X, Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-07-19 | AVRO | Buy | 810,811 | 18.50 | 15,000,003 |
Table 4. Insider trading of Dianthus Therapeutics, Inc. /de/ (MGTA) by Atlas Venture Associates X, Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-03-20 | MGTA | Sale | 14,245 | 17.86 | 254,415 |
Table 5. Insider trading of Kymera Therapeutics, Inc. (KYMR) by Atlas Venture Associates X, Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-08-11 | KYMR | Sale | 242,133 | 61.00 | 14,770,113 |
2021-03-12 | KYMR | Sale | 229,350 | 56.50 | 12,958,275 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Atlas Venture Associates X, Llc
(10% Owner of Disc Medicine, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.